Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.6.4 now appears in the record history, replacing Revision: v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-25T22:58:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.
    Difference
    0.1%
    Check dated 2026-07-04T13:09:05.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed.
    Difference
    0.1%
    Check dated 2026-06-27T06:30:25.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The study record history shows Vojtech Melenovsky, MD, PhD listed as the responsible party, adds 'Last verified' and 'Last known status' details, and records a new Revision: v3.6.0; older entries including 'Last known status was:', 'Verified', and Revision: v3.5.5 are removed.
    Difference
    3%
    Check dated 2026-06-13T01:09:20.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 is now shown in the study record's history, replacing the previous v3.5.4. This indicates an update to the record's metadata.
    Difference
    0.1%
    Check dated 2026-06-05T21:58:45.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The page now presents the study header and provenance details along with a version-history section, including the study title, sponsor, investigator, and dates for study record versions.
    Difference
    10%
    Check dated 2026-05-29T18:40:46.000Z thumbnail image

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.